Back to Search
WILLIAM SCHELMAN, M.D., PH.D.
M.D., PH.D.
Medical Oncology Physician
NPI: 1023073137Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
43774(WI)
Research & Publications (8)
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
PMID 19082825·Cancer Chemother Pharmacol·2009
3-trial
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
PMID 18172649·Cancer Chemother Pharmacol·2008
3-trial
Glutamate mediates cell death and increases the Bax to Bcl-2 ratio in a differentiated neuronal cell line.
PMID 15363891·Brain Res Mol Brain Res·2004
7-preclinical
Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
PMID 15337314·Brain Res Mol Brain Res·2004
7-preclinical
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
PMID 18941749·Cancer Chemother Pharmacol·2009
4-observational
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
PMID 18061679·J Inorg Biochem·2008
8-other
Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures.
PMID 15168905·Brain Res Bull·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 263-8090
Quick Facts
- NPI
- 1023073137
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile